BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 6968449)

  • 21. [Clinical-functional diagnosis of pancreas carcinoma. With special consideration of the pancreozymin-secretin test and proteolytic stool enzyme activity].
    Filippini L; Ammann R
    Schweiz Med Wochenschr; 1967 Jun; 97(25):803-10. PubMed ID: 5592579
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnostic value of direct and indirect pancreatic function tests in chronic pancreatitis].
    Otte M
    Dtsch Med Wochenschr; 1989 Oct; 114(43):1662-4. PubMed ID: 2806097
    [No Abstract]   [Full Text] [Related]  

  • 23. [The secretin-pancreozymin test in the diagnosis of exocrine pancreatic function (author's transl)].
    Pointner H
    Wien Klin Wochenschr; 1973 Oct; 85(40):665-7. PubMed ID: 4747003
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical importance of the secretin-pancreozymin test in the diagnosis of chronic and neoplastic exocrine pancreatopathies].
    Taschieri AM; Pucci C; Scortecci V; Trivellini G
    Arch Ital Chir; 1967; 93(1):697-713. PubMed ID: 5621876
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison between bolus injection and infusion of secretin and pancreozymin in the diagnosis of chronic pancreatic disease (one hour test).
    Farini R; Del Favero G; Adorati M; Pedrazzoli S; Fabris G; Giordano P; D'Angelo A; Zotti E; Lise M; Chiaramonte M; Salvagnini M; Naccarato R
    Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):462-8. PubMed ID: 602625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The study of exocrine pancreas function by means of orally administered N-benzoyl-L-tyrosyl-praaminobenzoic acid (BT-PABA-test). Evaluation after 5 years clinical experience].
    Lang C; Gyr K; Borer P; Kayasseh L; Stalder GA
    Schweiz Med Wochenschr; 1980 Apr; 110(14):522-8. PubMed ID: 6966425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood serum secretin-pancreozymin test in diagnosis of chronic pancreatitis].
    Timoshina IV
    Sov Med; 1975 Feb; (2):73-7. PubMed ID: 1145285
    [No Abstract]   [Full Text] [Related]  

  • 28. [Secretin-pancreozymin test in chronic pancreatitis].
    da Cunha Mde A; de Gouveia OF; Franco S; Teixeira D; Galper E
    Hospital (Rio J); 1968 Jul; 74(1):67-77. PubMed ID: 5305567
    [No Abstract]   [Full Text] [Related]  

  • 29. [Determination of chymotrypsin in the stool by succinyl-L-phenylalanin-P-nitraniliden (Suphepa) in the diagnosis of pancreatic diseases (author's transl)].
    Löffler A; Ernst R; Miederer SE; Stadelmann O
    Med Klin; 1975 Oct; 70(43):1755-8. PubMed ID: 1186580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Faecal chymotrypsin for investigation of exocrine pancreatic function: a comparison of two newly developed tests with the titrimetric method.
    Ehrhardt-Schmelzer S; Otto J; Schlaeger R; Lankisch PG
    Z Gastroenterol; 1984 Nov; 22(11):647-51. PubMed ID: 6516499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modern pancreatic function tests].
    Hauzeur F; Dummler W
    Z Gesamte Inn Med; 1979 May; 34(10):277-80. PubMed ID: 314709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diseases of the exocrine pancreas in newborns and infants. A review. 2.: Organic pancreatic diseases (pancreatitis)].
    Niessen KH
    Fortschr Med; 1980 Mar; 98(9):319-24. PubMed ID: 6989727
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cholecystokinin-secretin test and ultrasonography in the diagnosis of chronic pancreatitis].
    Dítĕ P; Vítek J; Trojanová J; Spitzer D
    Vnitr Lek; 1982 Mar; 28(3):237-40. PubMed ID: 7112968
    [No Abstract]   [Full Text] [Related]  

  • 34. Pancreatic excretion test and barrier hypothesis in progression of chronic pancreatitis.
    Noda A; Hayakawa T; Horiguchi Y; Naruse S; Iinuma Y
    Am J Gastroenterol; 1978 Jun; 69(6):673-82. PubMed ID: 707463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Does the secretin/pancreozymin test require a correction for volume loss?].
    Hauzeur F
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(4):178-81. PubMed ID: 3436281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The PABA-peptide test: a method in diagnosis of exocrine pancreatic insufficiency (author's transl)].
    Schneiber E; Burgislaus E
    Med Klin; 1979 Jun; 74(25):1000-3. PubMed ID: 314038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary PABA recovery after oral N-benzoyl-L-tyrosyl-PABA administration combined with various exocrine pancreatic stimulants.
    Cavallini G; Piubello W; Brocco G; Barba E; Baratta S; Dobrilla G; Parolin P; Bonoldi C; Scuro LA
    Hepatogastroenterology; 1980 Jun; 27(3):224-6. PubMed ID: 6970160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis of pancreas function by electrolyte and trace element determination in endoscopically obtained pancreatic juice following secretin/pancreozymin stimulation].
    Neymeyer HG; Friedel E; Schulz HJ; Glatzel E; Siebert R
    Z Med Lab Diagn; 1983; 24(8):476-7. PubMed ID: 6673384
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the oral (PABA) pancreatic function test, the secretin-pancreozymin test and endoscopic retrograde pancreatography in chronic alcohol induced pancreatitis.
    Mee AS; Girdwood AH; Walker E; Gilinsky NH; Kottler RE; Marks IN
    Gut; 1985 Nov; 26(11):1257-62. PubMed ID: 3877666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance of the evocation test, chymotrypsin and lipid determination in feces for the diagnosis of pancreatic diseases].
    Sommer H; Kasper H; Chimombe AE
    Verh Dtsch Ges Inn Med; 1974; 80():548-9. PubMed ID: 4454618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.